Real World Observational Study of Sotatercept for Pulmonary Hypertension
Recruiting · NCT06751082 · Observational (researchers observe without assigning treatment) · Lead sponsor: Mayo Clinic
View the official record on ClinicalTrials.gov →What this trial is about
The purpose of this study seeks to describe the real world initial experience with sotatercept in the treatment of pulmonary hypertension.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Adults age 18 or greater who are being treated with sotatercept in the Mayo Pulmonary hypertension clinic.
Exclusion criteria
- Adults lacking capacity to consent
Where it is running
1 location listed across 1 US state.
- Mayo Clinic - Rochester, Minnesota, United States